ProMeTeus: Membrane protein integrated technologies development for drug design
EXTREMOCHEM LDA
participó en un
H2020:
H2020-MSCA-RISE-2018
The aim of the ProMeTeus Consortium is to provide high-quality multidisciplinary knowledge through training and research on the development...
2018-10-04 - 2023-12-31 | Financiado
2018-10-04 - 2023-12-31 | Financiado
ExtremoChem: Chemically synthesised novel compounds for the stabilisation of biologics
EXTREMOCHEM LDA
tramitó un
H2020:
H2020-SMEInst-2016-2017
Biologics are medical drugs produced using biotechnology, other than direct extraction from a native biological source. Many of biopharmaceu...
2016-12-09 - 2017-03-31 | Financiado
2016-12-09 - 2017-03-31 | Financiado
* No se disponen de datos de la empresa actual.